Glucocorticoid-remediable aldosteronism

Affiliations

Review

R G Dluhy et al. Cardiovasc Res. 1996 Jun.

. 1996 Jun;31(6):870-2.

No abstract available

Comment in

Hypertension: a case of the gratuitous rider.
Weber KT. Weber KT. Cardiovasc Res. 1996 Jun;31(6):868-9. Cardiovasc Res. 1996. PMID: 8759240 No abstract available.

The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
Lifton RP, Dluhy RG, Powers M, Ulick S, Lalouel JM. Lifton RP, et al. Trans Assoc Am Physicians. 1992;105:64-71. Trans Assoc Am Physicians. 1992. PMID: 1309006 No abstract available.
Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoid hypertension.
Comiter CV, Capelouto CC, Tobin MS, Dluhy RG, Richie JP. Comiter CV, et al. J Urol. 1995 Aug;154(2 Pt 1):510-2. J Urol. 1995. PMID: 7609119 Review. No abstract available.
Glucocorticoid-remediable aldosteronism.
McMahon GT, Dluhy RG. McMahon GT, et al. Cardiol Rev. 2004 Jan-Feb;12(1):44-8. doi: 10.1097/01.crd.0000096417.42861.ce. Cardiol Rev. 2004. PMID: 14667264 Review.
Glucocorticoid-remediable aldosteronism.
Dluhy RG, Lifton RP. Dluhy RG, et al. Endocrinol Metab Clin North Am. 1994 Jun;23(2):285-97. Endocrinol Metab Clin North Am. 1994. PMID: 8070423 Review.
[Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].
Lurbe E, Chaves FJ, Torró I, Armengod ME, Alvarez V, Redon J. Lurbe E, et al. Med Clin (Barc). 1999 Nov 6;113(15):579-82. Med Clin (Barc). 1999. PMID: 10605685 Review. Spanish.